Helix BioMedix (HXBM) Stock Price
Helix BioMedix Price
Revenue has compounded at 45.4% per year over the past 14 years to 1.89 M USD. Helix BioMedix's net margin stands at -131.6%, up from -741.7% several years earlier.
Helix BioMedix stock price
Helix BioMedix business model & stock analysis
Frequently asked questions about Helix BioMedix
Converted at the current exchange rate, the Helix BioMedix share trades at 2.94 EUR (3.29 USD).
The revenue cannot currently be calculated for Helix BioMedix.
The profit cannot currently be calculated for Helix BioMedix.
The P/E ratio cannot be calculated for Helix BioMedix at the moment.
The P/S cannot be calculated for Helix BioMedix currently.
The Eulerpool Quality Score for Helix BioMedix is 4/10.
The ISIN of Helix BioMedix is US4232875074. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Helix BioMedix is HXBM. The ticker symbol is used to trade Helix BioMedix shares on the stock exchange.
Helix BioMedix stock
Helix BioMedix Peer Group
Helix BioMedix Ticker
Helix BioMedix FIGI
All fundamentals and in-depth analysis of Helix BioMedix
Our stock analysis for Helix BioMedix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Helix BioMedix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.